SHANGHAI, China, Dec. 18 WuXi PharmaTech (NYSE: WX),a leading pharmaceutical, biotechnology and medical device research anddevelopment outsourcing company with operations in China and the United States,announced today that its rodent facility in Shanghai has receivedaccreditation from the Association for the Assessment and Accreditation ofLaboratory Animal Care (AAALAC) International.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
AAALAC International is a private, nonprofit organization that promotesthe humane treatment of animals in science through voluntary accreditation andassessment programs. As a result of an extensive on-site evaluation, AAALACdetermined that WuXi PharmaTech's rodent facility is committed to the highestlevel of animal care and research practices.
AAALAC noted the following in its official approval letter: "The WuXiPharmaTech China management and staff are commended for providing goodfacilities and programs for the care and use of laboratory animals. Especiallynoteworthy were the strong institutional commitment to the animal care and useprogram; the conscientious and capable Institutional Animal Care and UseCommittee (IACUC); the knowledgeable and experienced animal care and use staff;excellent documentation (Standard Operating Procedures and guidelines) andrecords; and a well maintained, state-of-the-art facility. The attention todetail and completeness was exceptional."
"The AAALAC accreditation comes as a result of our efforts in expandingservice capabilities from chemistry to preclinical drug development includingdrug metabolism (DMPK) and toxicology," commented Dr. Ge Li, Chairman andChief Executive Officer of WuXi PharmaTech. "We are pleased to receive suchhigh praise from the leading independent world body on the care and use oflaboratory animals and we could not be more proud of the report issued byAAALAC. We are confident of being at the top of our industry with theendorsement of AAALAC."
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech providespharmaceutical, biotechnology and medical device companies a broad andintegrated portfolio of laboratory and manufacturing services throughout thedrug and medical device R&D process. WuXi PharmaTech's services are designedto assist its global partners in shortening the cycle and lowering the cost ofdrug and medical device R&D. The operating subsidiaries of WuXi PharmaTech areknown as WuXi AppTec. For more information, please visit:http://www.wuxiapptec.com .For more information, please contact: Sherry Shao WuXi PharmaTech (Cayman) Inc. Tel: +86-21-5046-4002 Email: firstname.lastname@example.org
SOURCE WuXi PharmaTech (Cayman) Inc.